Cargando…

Selective antitumor activity of roscovitine in head and neck cancer

Radiation and chemotherapy that are commonly used to treat human cancers damage cellular DNA. DNA damage appears to be more toxic to cancer cells than normal cells, most likely due to deregulated checkpoint activation and/or deficiency in DNA repair pathways that are characteristics of many tumors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gary, Cyril, Hajek, Michael, Biktasova, Asel, Bellinger, Gary, Yarbrough, Wendell G., Issaeva, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122414/ https://www.ncbi.nlm.nih.gov/pubmed/27233076 http://dx.doi.org/10.18632/oncotarget.9560

Ejemplares similares

Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells
por: Hajek, Michael, et al.
Publicado: (2020)

Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer
por: Pan, Cassie, et al.
Publicado: (2018)

Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner
por: Wamsley, J J, et al.
Publicado: (2017)

TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma
por: Hajek, Michael, et al.
Publicado: (2017)

NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents
por: Pan, Cassie, et al.
Publicado: (2019)

NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer
por: Schrank, Travis P., et al.
Publicado: (2022)

HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis
por: Pan, Cassie, et al.
Publicado: (2018)

APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2019)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers
por: Cheng, Hui, et al.
Publicado: (2018)

Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer
por: Papini, Christina, et al.
Publicado: (2022)

Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer
por: Papini, Christina, et al.
Publicado: (2022)

EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations
por: Rehmani, Hina S., et al.
Publicado: (2020)

Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
por: Roh, Jong-Lyel, et al.
Publicado: (2014)

Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis
por: Pandey, Vimal, et al.
Publicado: (2019)

Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas
por: Haider, Stefan P., et al.
Publicado: (2020)

Correction: Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration
por: Schrank, Travis P., et al.
Publicado: (2022)

Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells
por: Cui, Chunying, et al.
Publicado: (2013)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

Evaluation of Patient-Reported Delays and Affordability-Related Barriers to Care in Head and Neck Cancer
por: Lenze, Nicholas R., et al.
Publicado: (2021)

National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database
por: Schwam, Zachary G., et al.
Publicado: (2015)

Roscovitine ameliorates endotoxin-induced uveitis through neutrophil apoptosis
por: Jiang, Zhao-Xin, et al.
Publicado: (2016)

The molecular determinants of R-roscovitine block of hERG channels
por: Cernuda, Bryan, et al.
Publicado: (2019)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

The Cdk5 inhibitor Roscovitine increases LTP induction in corticostriatal synapses
por: Miranda-Barrientos, Jorge, et al.
Publicado: (2014)

Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation
por: Xie, Tiancheng, et al.
Publicado: (2017)

Effect of roscovitine on developmental competence of small follicle-derived buffalo oocytes
por: Pandey, Sriti, et al.
Publicado: (2018)

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy
por: Tejero, Rocio, et al.
Publicado: (2020)

MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer
por: Zwittag, Paul, et al.
Publicado: (2023)

Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
por: Nair, Binoj C, et al.
Publicado: (2011)

Cancer therapy by restoration of immune Notch
por: Shanker, Anil, et al.
Publicado: (2013)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Enhancement of Peripheral Nerve Regrowth by the Purine Nucleoside Analog and Cell Cycle Inhibitor, Roscovitine
por: Law, Vincent, et al.
Publicado: (2016)

Roscovitine enhances all-trans retinoic acid (ATRA)-induced nuclear enrichment of an ensemble of activated signaling molecules and augments ATRA-induced myeloid cell differentiation
por: Rashid, Asif, et al.
Publicado: (2020)

Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents
por: Montanaro, Gabriele, et al.
Publicado: (2013)

Interference with platelet-derived growth factor-induced signalling in vascular smooth muscle cells by roscovitine
por: Sroka, Irene, et al.
Publicado: (2008)

Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine
por: Węsierska-Gądek, Józefa, et al.
Publicado: (2007)

The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice
por: Rabhi, Nabil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvdgs2alhiabj3nfsvj02kftl3